Drug Type Chemical drugs, Therapeutic radiopharmaceuticals, Drug conjugates |
Synonyms 187 Re ethylenedicysteine glucosamine, ethylenedicysteine glucosamine drug conjugates (CellPoint) |
Target |
Mechanism DNA inhibitors(DNA inhibitors), Apoptosis stimulants, DNA cross linking agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Lymphoma | Preclinical | US | - | |
B-Cell Lymphoma | Preclinical | US | - | |
Lung Cancer | Preclinical | US | - | |
Lung Cancer | Preclinical | US | - |